HP
PRTA icon

HealthInvest Partners’s Prothena Corp PRTA Stock Holding History

HealthInvest Partners’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,342
Closed -$303K – 49
2023
Q4 		$303K Buy
+8,342
New +$321K 0.24% 45
2022
Q4 		$7.89K Buy
+131
New +$7.67K 0.02% 42

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

HealthInvest Partners's PRTA Position: Q1 2024 in Review

HealthInvest Partners sold out of Prothena Corp (PRTA) in Q1 2024, closing a stake of 8,342 shares — an estimated $303K sold.

HealthInvest Partners first reported a position in PRTA in Q4 2022 and held it in 2 quarters. The position peaked at $303K in Q4 2023. 169 funds tracked by Wall St. Rank hold PRTA as of Q1 2024.

  • HealthInvest Partners reported no remaining Prothena Corp position as of Q1 2024 after selling out during the quarter.
  • HealthInvest Partners sold 8,342 Prothena Corp shares in Q1 2024, an estimated $303K.
  • HealthInvest Partners first reported a position in Prothena Corp in Q4 2022 and held it in 2 quarters.
  • HealthInvest Partners's Prothena Corp position peaked at $303K in Q4 2023.
  • 169 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2024.

Based on HealthInvest Partners's 13F filing for Q1 2024, filed 25 Apr 2024.